Senator Orrin Hatch and Senator Kamala Harris ask Attorney General Jeff Sessions to get the DEA to allow medical marijuana research; current and former executives of pharmaceutical distributors are scheduled to testify before Congress May 8 about their role in the opioid epidemic; 14 patients on Vieques, a Puerto Rican island just east of the main island, are flying 3 times a week for lifesaving dialysis more than 6 months after Hurricane Maria.
Bipartisan senators wrote Attorney General Jeff Sessions to ask him to cease efforts by the Drug Enforcement Agency (DEA) to slow medical marijuana research. Senator Orrin Hatch, R-Utah, and Senator Kamala Harris, D-California, said that they are concerned the Justice Department is effectively blocking the DEA from taking action on at least 25 formal applications from manufacturers to produce federally approved research-grade marijuana, The Hill reported. Such research is needed for “evidence-based decision making,” they wrote.
Current and former executives of pharmaceutical distributors are scheduled to testify before Congress May 8 about their role in the opioid epidemic, reported The Washington Post. The hearing before a House Energy and Commerce Committee oversight panel is being likened to when tobacco executives were called to testify before Congress in 1994. Under oath, the executives are expected to face tough questions about why their companies sent so many highly addictive pain pills into West Virginia and other states, fueling the drug crisis.
Fourteen patients on Vieques, a Puerto Rican island just east of the main island, are flying 3 times a week for lifesaving dialysis more than 6 months after Hurricane Maria because the only hospital and dialysis clinic was destroyed, Kaiser Health News reported. When patients with diabetes and kidney failure will be able to regain their treatments locally is uncertain, as federal, local officials, and nonprofit groups debate strategy and finances. The responsibility of paying for the flights, which turn into 12-hour ordeals to get from Vieques to the main island, continues to switch between groups.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More